SI-BONE Inc (FRA:2K3)
€ 13.4 0.2 (1.5%) Market Cap: 571.51 Mil Enterprise Value: 463.38 Mil PE Ratio: 0 PB Ratio: 3.58 GF Score: 63/100

SI-BONE Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 12:00PM GMT
Release Date Price: €17.5 (+3.55%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

All right. Good morning, everybody. I'm Andrew Ranieri, one of the medical device analysts here at Morgan Stanley. And it's my pleasure to have SI-BONE with us today, Laura Francis CEO; and Anshul Maheshwari, the CFO.

Before I jump into kind of Q&A, I just have to go through our disclosure. But for important disclosures, please see the Morgan research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please feel free to reach out to your Morgan Stanley sales rep.

But again, pleasure to have you both here with us in town live and in the flesh.

Laura A. Francis
SI-BONE, Inc. - CEO & Director

Thanks, you too.

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thanks for coming and maybe how we kind of like to -- how I'd kind of like to spend the 30 minutes is just to kind of briefly touch on macro factors and some of the things that we've heard

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot